| | |
Diagnostic Substances News
|
| | View:
Latest News | Top Stories | | | Tuesday, Dec 15, 2009 | | | · | Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010
PR Newswire -
Tue 4:01 pm ET | | | · | EpiCept Provides Clinical and Business Update on Ceplene Program
Business Wire -
Tue 12:01 am ET | | | Monday, Dec 14, 2009 | | | · | Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM)
PR Newswire -
Mon 9:15 am ET | | | · | BrainStorm Announces Date for Webcast Audio Conference
Business Wire -
Mon 9:00 am ET | | | · | U.K. Police Force Veteran, Dr. James M. Hart, to Join Orchid Cellmark Board of Directors
GlobeNewswire -
Mon 7:00 am ET | | | Sunday, Dec 13, 2009 | | | · | Celldex Therapeutics Presents Positive Results from Phase 2 Study of the Antibody-Drug Conjugate (ADC) Product Candidate CDX-011 in Advanced Breast Cancer
Business Wire -
Sun Dec 13 | | | Friday, Dec 11, 2009 | | | · | EpiCept to Present at Lippert/Heilshorn & Associates Life Sciences Virtual Conference
Business Wire -
Fri Dec 11 | | | Thursday, Dec 10, 2009 | | | · | Nymox Pharmaceuticals gets $15M financing deal
AP -
Thu Dec 10 | | | · | Nymox Announces New $15 Million Equity Financing Commitment
GlobeNewswire -
Thu Dec 10 | | | · | Do Gene Sequences Deserve Patent Protection?
at The Wall Street Journal Online -
Thu Dec 10 | | | · | Biomoda Partners with Christiana Care to Complete Pilot Study on Cancer Diagnostic
Business Wire -
Thu Dec 10 | | | · | Neogen Corporation Announces 2nd Quarter Results
PR Newswire -
Thu Dec 10 | | | Wednesday, Dec 9, 2009 | | | · | Rosetta Genomics to Hold Business Update, Pipeline Progress and Third Quarter Conference Call on December 18
Business Wire -
Wed Dec 9 | | | Tuesday, Dec 8, 2009 | | | · | AMAG Pharmaceuticals, Inc. to Present at the Deutsche Bank 2009 Biotech Boston Confab Conference
Business Wire -
Tue Dec 8 | | | · | Quidel Authorizes Additional $25 Million under Stock Repurchase Program
Business Wire -
Tue Dec 8 | | | · | Immunomedics Reports Updated Results of Subcutaneous Humanized Anti-CD20 Antibody Therapy of Lymphoma With Veltuzumab
GlobeNewswire -
Tue Dec 8 | | | Monday, Dec 7, 2009 | | | · | Immunomedics Announces Preclinical Results of Milatuzumab in B-Cell Malignancies
GlobeNewswire -
Mon Dec 7 | | | · | [external] Infinity Pharma promotes Perkins as CEO
at bizjournals.com -
Mon Dec 7 | | | · | Celldex Therapeutics to Present CDX-011 Clinical Data at the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium
Business Wire -
Mon Dec 7 | | | · | Follow-Up Results of Two Clinical Studies With Veltuzumab and Epratuzumab reported At ASH
GlobeNewswire -
Mon Dec 7 | |
|
More Latest News...
|
| |
|
